Biomarin Pharmaceutical BMRN
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$24.02M (16 inflow days, 4 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 33.7% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 5.27% to 7.30% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +2,091,372 | 3.5% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +538,823 | 4.3% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +520,743 | 1.3% |
| Strategic Advisers LLC | Mutual Fund | 2026/Q3 | +428,794 | 0.3% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +323,167 | 2.3% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +275,900 | 0.4% |
| Morgan Stanley | Public Company | 2026/Q3 | +257,323 | 0.9% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +257,323 | 0.9% |
| Vestal Point Capital, LP | Hedge Fund | 2026/Q3 | +2,450,000 | 3.1% |
| Deep Track Capital, LP | VC/PE Fund | 2026/Q3 | +2,157,481 | 1.7% |
| FMR | Mutual Fund | 2026/Q3 | +1,147,648 | 2.4% |
| ARGA Investment Management, LLC | Mutual Fund | 2026/Q3 | +1,039,409 | 0.5% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +831,878 | 0.5% |
| Defilade Capital Management, L.P. | Hedge Fund | 2026/Q3 | +682,005 | 0.4% |
| Norges Bank Investment Management | Sovereign Wealth Fund | 2026/Q3 | +676,874 | 4.2% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 29 Sep 2026 | Gregory Friberg | Executive VP and Chief Research & Development Officer | Sale to Issuer | -4,086 | $60.00 | 47,732 |
| 9 Sep 2026 | Robert Plenge | Independent Director | Other Acquisition | +6,140 | – | 6,140 |
| 1 Sep 2026 | George Davis | Executive Vice President | Open Market Disposition | -17,557 | $66.28 | 61,003 |
| 1 Jun 2026 | Mark Enyedy | Independent Director | Other Acquisition | +7,490 | – | 7,490 |
| 1 Jun 2026 | Ian T. Clark | Independent Chairperson | Other Acquisition | +7,490 | – | 14,490 |
| 1 Jun 2026 | Willard Dere | Independent Director | Other Acquisition | +7,490 | – | 14,140 |
| 1 Jun 2026 | Timothy Walbert | Independent Director | Other Acquisition | +7,490 | – | 7,490 |
| 1 Jun 2026 | Maykin Ho | Independent Director | Other Acquisition | +7,490 | – | 7,490 |
| 1 Jun 2026 | Robert Hombach | Independent Director | Other Acquisition | +7,490 | – | 14,140 |
| 1 Jun 2026 | Athena Countouriotis | Independent Director | Other Acquisition | +7,490 | – | 7,490 |
| 1 Jun 2026 | Elizabeth Anderson | Independent Director | Other Acquisition | +7,490 | – | 7,490 |
| 1 Jun 2026 | Barbara Bodem | Independent Director | Other Acquisition | +7,490 | – | 7,490 |
| 19 May 2026 | Cristin Hubbard | Executive Vice President | Sale to Issuer | -2,318 | $50.20 | 7,384 |
| 6 May 2026 | Gregory Friberg | Executive VP and Chief Research & Development Officer | Open Market Disposition | -3,281 | $53.85 | 51,818 |
| 17 Mar 2026 | George Davis | Executive Vice President | Sale to Issuer | -1,273 | $56.05 | 78,560 |
| 16 Mar 2026 | Alexander Hardy | Chief Executive Officer | Sale to Issuer | -4,252 | $56.05 | 214,635 |
| 16 Mar 2026 | Brian Mueller | CFO & Executive VP of Finance | Sale to Issuer | -2,117 | $56.05 | 123,314 |
| 16 Mar 2026 | Gregory Friberg | Executive VP and Chief Research & Development Officer | Sale to Issuer | -1,629 | $56.05 | 55,099 |
| 16 Mar 2026 | Cristin Hubbard | Executive Vice President | Sale to Issuer | -1,245 | $56.05 | 7,580 |
| 16 Mar 2026 | C. Guyer | Executive Vice President | Sale to Issuer | -1,693 | $56.05 | 74,158 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 14,122,815 | 7.3% | 5.8 |
| 15 Oct 2026 | 12,050,657 | 6.2% | 4.9 |
| 30 Sep 2026 | 11,522,835 | 6.0% | 5.5 |
| 15 Sep 2026 | 10,075,655 | 5.2% | 5.5 |
| 31 Aug 2026 | 9,877,553 | 5.1% | 5.8 |
| 14 Aug 2026 | 10,202,950 | 5.3% | 3.7 |
No comments yet — be the first to weigh in on BMRN.
Sign in to join the discussion.